Cerus Corp (CERS) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Cerus reported revenue of $233.8M, up 16.1% from $201.3M the year before. Net income was -$15.6M (a -6.7% net margin), or -$0.08 per diluted share. Gross margin was 59.9% and operating margin was -3.7%. Operating activities generated $4.8M of cash, leaving $1.1M of free cash flow. At fiscal year end, Cerus held $221.9M in total assets against $156.9M in total liabilities, including $20.0M of cash and equivalents.
Open the full interactive Cerus financials → Quarterly statements, key ratios, valuation history and price charts.
Cerus Key Stats
| Share Price | $2.26 |
|---|---|
| Market Cap | $453.3M |
| Revenue YoY Growth | +16.1% |
| 52-Week Range | $1.40 – $3.28 |
| Shares Outstanding | 200.6 million (basic, 2026 Q2) |
Cerus Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $114.2M | $159.5M | $188.3M | $186.8M | $201.3M | $233.8M |
| Cost of Goods Sold | $41.2M | $63.5M | $75.0M | $70.0M | $80.7M | $93.8M |
| Gross Profit | $73.1M | $96.0M | $113.4M | $116.8M | $120.6M | $140.0M |
| Operating Income | -$58.3M | -$48.9M | -$34.1M | -$30.1M | -$14.2M | -$8.7M |
| Pre-Tax Income | -$59.6M | -$54.1M | -$42.3M | -$37.3M | -$20.8M | -$15.3M |
| Income Tax | $284,000 | $319,000 | $488,000 | $325,000 | $205,000 | $354,000 |
| Net Income | -$59.9M | -$54.4M | -$42.8M | -$37.5M | -$20.9M | -$15.6M |
| Diluted EPS | -$0.37 | -$0.32 | -$0.24 | -$0.21 | -$0.11 | -$0.08 |
Cerus Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $52.7M | $85.4M | $53.7M | $57.4M |
| Net Income | -$19,000 | -$2.2M | -$1.6M | -$2.9M |
| Diluted EPS | — | -$0.01 | -$0.01 | -$0.01 |
Cerus Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $36.6M | $48.8M | $35.6M | $11.6M | $20.3M | $20.0M |
| Current Assets | $183.4M | $187.1M | $170.1M | $144.4M | $152.0M | $174.4M |
| Total Assets | $221.4M | $237.5M | $218.1M | $197.7M | $200.9M | $221.9M |
| Current Liabilities | $60.0M | $78.6M | $117.1M | $67.5M | $63.6M | $100.8M |
| Total Long-Term Debt | $48.1M | $69.4M | $69.8M | $79.8M | $84.2M | $83.9M |
| Total Liabilities | $117.6M | $151.9M | $149.5M | $144.3M | $144.0M | $156.9M |
| Shareholders' Equity | $103.8M | $84.6M | $67.6M | $52.6M | $56.1M | $64.2M |
Cerus Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$40.7M | -$33.9M | -$25.6M | -$43.2M | $11.4M | $4.8M |
| Cash From Investing | -$49.6M | $12.7M | $8.5M | $8.6M | -$8.1M | -$6.2M |
| Cash From Financing | $91.8M | $34.3M | $4.2M | $10.7M | $5.0M | $231,000 |
| Free Cash Flow | -$42.4M | -$34.8M | -$27.6M | -$47.8M | $8.5M | $1.1M |
Figures from Cerus' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Cerus financials page for every line item.
Cerus Company Profile
| Ticker | CERS |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Concord, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer |
| SEC CIK | 0001020214 |
Frequently Asked Questions
What was Cerus' revenue in fiscal 2025?
Cerus (CERS) reported revenue of $233.8M for fiscal 2025.
What is Cerus' annual revenue history?
Cerus' annual revenue by fiscal year: 2020: $114.2M; 2021: $159.5M; 2022: $188.3M; 2023: $186.8M; 2024: $201.3M; 2025: $233.8M.
What was Cerus' net income in fiscal 2025?
Cerus reported net income of -$15.6M for fiscal 2025.
What was Cerus' earnings per share (EPS) in fiscal 2025?
Cerus' diluted EPS was -$0.08 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Cerus generate in fiscal 2025?
Cerus generated $1.1M of free cash flow in fiscal 2025.
What was Cerus' revenue last quarter?
In its most recent reported quarter (2026 Q2), Cerus reported revenue of $57.4M.
How much debt does Cerus have?
Cerus reported $83.9M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Cerus are outstanding?
Cerus reported a weighted average of 200.6 million basic shares outstanding in 2026 Q2.
What is Cerus' market cap?
Based on its latest closing price, Cerus (CERS) has a market capitalization of about $453.3M.
When does Cerus' fiscal year end?
Cerus' fiscal year end, as registered with the SEC, is December 31.
Where is Cerus headquartered?
Cerus lists its business address in Concord, California in its SEC filings.
Cerus Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →